Avantor® Announces Secondary Offering of 38,500,000 Shares of Common Stock
Avantor, Inc. (NYSE: AVTR) announced an underwritten secondary offering of 38,500,000 shares of common stock by certain stockholders, including an affiliate of New Mountain Capital. The underwriters, Goldman Sachs & Co. LLC and J.P. Morgan, may acquire an additional 5,775,000 shares. The proceeds will go entirely to the selling stockholders, as no shares are being sold by the company itself. A registration statement with the SEC has been filed and is effective. The offering will be conducted via a prospectus supplement.
- The secondary offering could enhance liquidity for existing shareholders.
- Increased visibility as a result of the stock offering may attract more investors.
- The secondary offering could dilute existing shareholders' equity.
- Dependence on stockholder sales may indicate a lack of confidence in company growth from management.
RADNOR, Pa., Aug. 19, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR) ("Avantor" or the "Company"), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, today announced that certain of its stockholders (the "Selling Stockholders"), including an affiliate of New Mountain Capital, LLC, intend to offer for sale in an underwritten secondary offering 38,500,000 shares of common stock of the Company pursuant to a registration statement filed by the Company with the U.S. Securities and Exchange Commission (the "SEC"). The Selling Stockholders expect to grant the underwriters a 30-day option to purchase up to an additional 5,775,000 shares of common stock on the same terms and conditions. No shares are being sold by the Company. The Selling Stockholders will receive all of the proceeds from this offering.
Goldman Sachs & Co. LLC and J.P. Morgan are acting as the underwriters for the proposed offering.
A registration statement relating to these securities has been filed with the SEC and has become effective. This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
The offering of these securities will be made only by means of a prospectus supplement and accompanying prospectus. Copies of the preliminary prospectus supplement and accompanying prospectus for the offering, when available, may be obtained from Goldman Sachs & Co. LLC, Attention: Prospectus Department at 200 West Street, New York, NY 10282 or by telephone at 1-866-471-2526; or J.P. Morgan Securities LLC, Attention: Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone 1-866-803-9204 or by email at prospectus-eq_fi@jpmchase.com.
About Avantor
Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. One of our greatest strengths comes from having a global infrastructure that is strategically located to support the needs of our customers. Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world.
Forward Looking Statements
This press release contains forward-looking statements. All statements other than statements of historical fact included in this press release are forward-looking statements. Forward-looking statements discuss our current expectations and projections relating to our financial condition, results of operations, plans, objectives, future performance and business. These statements may be preceded by, followed by or include the words "aim," "anticipate," "believe," "estimate," "expect," "forecast," "intend," "likely," "outlook," "plan," "potential," "project," "projection," "seek," "can," "could," "may," "should," "would," "will," the negatives thereof and other words and terms of similar meaning.
Forward-looking statements are inherently subject to risks, uncertainties and assumptions; they are not guarantees of performance. You should not place undue reliance on these statements. We have based these forward-looking statements on our current expectations and projections about future events. Although we believe that our assumptions made in connection with the forward-looking statements are reasonable, we cannot assure you that the assumptions and expectations will prove to be correct. Factors that could contribute to these risks, uncertainties and assumptions include, but are not limited to, the factors described in "Risk Factors" in our most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, as such risk factors may be updated from time to time in our periodic filings with the SEC.
All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the foregoing cautionary statements. In addition, all forward-looking statements speak only as of the date of this press release. We undertake no obligations to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise other than as required under the federal securities laws.
Global Media Contact
Allison Hosak
Senior Vice President, Global Communications
Avantor
+1 908-329-7281
Allison.Hosak@avantorsciences.com
Investor Relations Contact
Tommy J. Thomas, CPA
Vice President, Investor Relations
Avantor
+1 781-375-8051
Tommy.Thomas@avantorsciences.com
View original content:http://www.prnewswire.com/news-releases/avantor-announces-secondary-offering-of-38-500-000-shares-of-common-stock-301115185.html
SOURCE Avantor and Financial News
FAQ
What is the purpose of Avantor's recent secondary offering?
Who are the underwriters for Avantor's stock offering?
How many additional shares can underwriters purchase in Avantor's offering?
What is the stock symbol for Avantor?
Will Avantor receive any proceeds from the stock offering?
